Increasing incidence of ciprofloxacin-resistant Neisseria gonorrhoeae infection in Canada

CMAJ. Canadian Medical Association Journal

Volumn 168, Issue 7, 2003, Pages 872-873

  Sarwal, Shelly ^a   Wong, Tom ^a   Sevigny, Cathy ^a   Ng, Lai King ^b  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b Natl Lab Sexually Transmitted Dis   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CEFIXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; OFLOXACIN; QUINOLONE DERIVATIVE;

ARTICLE; BACTERIAL TRANSMISSION; CANADA; GONORRHEA; GRAM STAINING; HUMAN; INCIDENCE; INFECTION PREVENTION; NEISSERIA GONORRHOEAE; URETHRITIS; UTERINE CERVICITIS;

EID: 0037390842     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Hansen L, Wong T, Mathias M. Gonorrhea resurgence in Canada. Int J STD AIDS. In press.
2. Reported gonorrhea cases and rates in Canada by age group and sex, 1980-2000 [table]. Ottawa: Division of Sexual Health Promotion and STD Prevention and Control, Bureau of HIV/AIDS, STD and TB, Health Canada; 2001. Available: www.hc-sc.gc.ca/pphb-dgspsp/std-mts/stddata1201/tab2-1_e.html (accessed 2003 Mar 6).
3. Reported cases and rates of notifiable STD from January 1 to September 30, 2002 and January 1 to September 30, 2001 [table]. Ottawa: Division of Sexual Health Promotion and STD Prevention and Control, Centre for Infectious Disease Prevention and Control, Health Canada. Available: www.hc-sc.gc.ca/pphb-dgspsp/std-mts/stdcases-casmts/index.html (accessed 2003 Mar 6).
4. World Health Organization. Global prevalence and incidence of selected curable sexually transmitted infections: overview and estimates. Geneva: The Organization; 2001.
5. Canadian STD guidelines: 1998 edition. Ottawa: Division of STD Prevention and Control, Bureau of HIV/AIDS, STD and TB, Laboratory Centre for Disease Control, Health Canada; 1998. Cat no H49-119/1998E. Available: www.hc-sc.gc.ca/pphb-dgspsp/publicat/std-mts98 (accessed 2003 Mar 6).
6. Ison C, Dillon J, Tapsall J. The epidemiology of global antibiotic resistance among Neisseria gonorrhoeae and Haemophilus ducreyi. Lancet 1998;351(Suppl 3):8-11.
7. Decreased susceptibility of Neisseria gonorrhoeae to fluoroquinolones - Ontario, 1992-1994. Can Commun Dis Rep 1995;21(3):1-3.
8. Neisseria gonorrhoeae with decreased susceptibility to ciprofloxacin in British Columbia: an imported phenomenon. Can Commun Dis Rep 1995;21(15):1-2.
9. Emergence of Neisseria gonorrhoeae strains with decreased susceptibility to ciprofloxacin - Quebec, 1994-1995. Can Commun Dis Rep 1996;22(15):1-5.
10. Fluoroquinolone-resistance in Neisseria gonorrhoeae, Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999. MMWR Morbid Mortal Wkly Rep 2000;49(37):833-7.
11. Fluoroquinolone-resistant Neisseria gonorrhoeae - San Diego, California, 1997. MMWR Morbid Mortal Wkly Rep 1998;47(20):405-8.
12. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae - Hawaii and California, 2001. MMWR Morbid Mortal Wkly Rep 2002;51(46):1041-4.